HALO : Halozyme Therapeutics stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year) with analysis
| subject | Average | Low | High | Change from close on 2021-09-24 |
|---|---|---|---|---|
| HALO : Halozyme Therapeutics stock forecast | $52.0 | $48.0 | $56.0 | 29.06% |
| HALO : Halozyme Therapeutics stock forecast 2021 | $40.77 | $39.85 | $42.09 | 1.19% |
| HALO : Halozyme Therapeutics stock forecast 2022 | $59.05 | $45.49 | $65.78 | 46.55% |
| HALO : Halozyme Therapeutics stock forecast 2023 | $64.69 | $62.77 | $65.93 | 60.56% |
| HALO : Halozyme Therapeutics stock forecast 2024 | $60.27 | $58.92 | $62.18 | 49.59% |
| HALO : Halozyme Therapeutics stock forecast 2025 | $55.85 | $54.43 | $58.14 | 38.61% |
| HALO : Halozyme Therapeutics stock forecast 2026 | $51.07 | $50.1 | $53.66 | 26.76% |
| HALO : Halozyme Therapeutics stock forecast 2027 | $51.53 | $50.27 | $52.59 | 27.9% |
| HALO : Halozyme Therapeutics stock forecast 2028 | $52.51 | $52.35 | $52.64 | 30.34% |
| HALO : Halozyme Therapeutics stock forecast 2029 | $52.2 | $52.14 | $52.33 | 29.57% |
| HALO : Halozyme Therapeutics stock forecast 2030 | $52.6 | $52.17 | $53.61 | 30.55% |
| HALO : Halozyme Therapeutics stock forecast 2031 | $55.72 | $53.99 | $57.54 | 38.29% |
The 2 Wall Street analysts offering Halozyme Therapeutics stock forecast in the last 6 months have average price target of
$52.0 with a high forecast of $56.0 and a low forecast of $48.0.
The average Halozyme Therapeutics stock forecast represents a 29.06%
increase from the last price of $40.2900009155273.
From AI system, total return is 2762.11% from 2523 forecasts.
For Halozyme Therapeutics stock forecast 2021, 3 predictions are offered for each month of 2021 with average Halozyme Therapeutics stock
forecast of $40.77, a high forecast of $42.09, and a low forecast of $39.85.
The average Halozyme Therapeutics stock forecast 2021 represents a 1.19%
increase from the last price of $40.2900009155273.
For Halozyme Therapeutics stock forecast 2022, 12 predictions are offered for each month of 2022 with average Halozyme Therapeutics stock
forecast of $59.05, a high forecast of $65.78, and a low forecast of $45.49.
The average Halozyme Therapeutics stock forecast 2022 represents a 46.55%
increase from the last price of $40.2900009155273.
For Halozyme Therapeutics stock forecast 2025, 12 predictions are offered for each month of 2025 with average Halozyme Therapeutics stock
forecast of $55.85, a high forecast of $58.14, and a low forecast of $54.43.
The average Halozyme Therapeutics stock forecast 2025 represents a 38.61%
increase from the last price of $40.2900009155273.
For Halozyme Therapeutics stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Halozyme Therapeutics stock
forecast of $51.07, a high forecast of $53.66, and a low forecast of $50.1.
The average Halozyme Therapeutics stock forecast 2026 represents a 26.76%
increase from the last price of $40.2900009155273.
For Halozyme Therapeutics stock forecast 2030, 12 predictions are offered for each month of 2030 with average Halozyme Therapeutics stock
forecast of $52.6, a high forecast of $53.61, and a low forecast of $52.17.
The average Halozyme Therapeutics stock forecast 2030 represents a 30.55%
increase from the last price of $40.2900009155273.
For Halozyme Therapeutics stock forecast 2031 (10 year), 9 predictions are offered for each month of 2031 with average Halozyme Therapeutics stock
forecast of $55.72, a high forecast of $57.54, and a low forecast of $53.99.
The average Halozyme Therapeutics stock forecast 2031 represents a 38.29%
increase from the last price of $40.2900009155273.
Please, see more forecasts below.
HALO : Halozyme Therapeutics stock forecast by Wall Street Analysts
The average Halozyme Therapeutics stock forecast from last 6 month is $52.0, and this show a -4.0% decrease in average from the prior price target of the each prediction. Also, this average forecast of $52.0 represents a -5.45% decrease from the past average forecast of $55.0, 6 months ago from 2 wall street analysts.
Halozyme Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| Halozyme Therapeutics stock forecast for 2021-09-27 | $42.49 | 5.46% |
| Halozyme Therapeutics stock forecast for 2021-09-28 | $44.67 | 5.12% |
| Halozyme Therapeutics stock forecast for 2021-09-29 | $44.34 | -0.73% |
| Halozyme Therapeutics stock forecast for 2021-09-30 | $45.48 | 2.57% |
| Halozyme Therapeutics stock forecast for 2021-10-01 | $47.97 | 5.46% |
Long term Halozyme Therapeutics (HALO) stock forecast for 2021, 2022 (1 year) - 2025, 2026 (5 year) - 2030, and 2031 (10 year)
Forecast for 2021 Oct. is $39.85 , for 2022 Sep. is $64.41 , for 2025 Sep. is $55.13 , for 2026 Sep. is $50.16 , for 2030 Sep. is $52.76 , and for 2031 Sep. is $57.54.
Halozyme Therapeutics (HALO) stock forecast 2021
| Date | Price Target | Change |
|---|---|---|
| Halozyme Therapeutics stock forecast 2021 Oct. | $39.85 | -1.09% |
| Halozyme Therapeutics stock forecast 2021 Nov. | $40.36 | 1.28% |
| Halozyme Therapeutics stock forecast 2021 Dec. | $42.09 | 4.28% |
Halozyme Therapeutics (HALO) stock forecast 2022
| Date | Price Target | Change |
|---|---|---|
| Halozyme Therapeutics stock forecast 2022 Jan. | $45.49 | 8.08% |
| Halozyme Therapeutics stock forecast 2022 Feb. | $48.88 | 7.46% |
| Halozyme Therapeutics stock forecast 2022 Mar. | $52.58 | 7.55% |
| Halozyme Therapeutics stock forecast 2022 Apr. | $55.89 | 6.31% |
| Halozyme Therapeutics stock forecast 2022 May. | $58.63 | 4.90% |
| Halozyme Therapeutics stock forecast 2022 Jun. | $60.71 | 3.55% |
| Halozyme Therapeutics stock forecast 2022 Jul. | $62.22 | 2.49% |
| Halozyme Therapeutics stock forecast 2022 Aug. | $63.44 | 1.96% |
| Halozyme Therapeutics stock forecast 2022 Sep. | $64.41 | 1.53% |
| Halozyme Therapeutics stock forecast 2022 Oct. | $65.03 | 0.96% |
| Halozyme Therapeutics stock forecast 2022 Nov. | $65.49 | 0.71% |
| Halozyme Therapeutics stock forecast 2022 Dec. | $65.78 | 0.43% |
Halozyme Therapeutics (HALO) stock forecast 2023
| Date | Price Target | Change |
|---|---|---|
| Halozyme Therapeutics stock forecast 2023 Jan. | $65.91 | 0.20% |
| Halozyme Therapeutics stock forecast 2023 Feb. | $65.93 | 0.02% |
| Halozyme Therapeutics stock forecast 2023 Mar. | $65.82 | -0.16% |
| Halozyme Therapeutics stock forecast 2023 Apr. | $65.60 | -0.33% |
| Halozyme Therapeutics stock forecast 2023 May. | $65.30 | -0.46% |
| Halozyme Therapeutics stock forecast 2023 Jun. | $65.01 | -0.45% |
| Halozyme Therapeutics stock forecast 2023 Jul. | $64.70 | -0.47% |
| Halozyme Therapeutics stock forecast 2023 Aug. | $64.38 | -0.49% |
| Halozyme Therapeutics stock forecast 2023 Sep. | $64.02 | -0.56% |
| Halozyme Therapeutics stock forecast 2023 Oct. | $63.62 | -0.63% |
| Halozyme Therapeutics stock forecast 2023 Nov. | $63.21 | -0.65% |
| Halozyme Therapeutics stock forecast 2023 Dec. | $62.77 | -0.69% |
Halozyme Therapeutics (HALO) stock forecast 2024
| Date | Price Target | Change |
|---|---|---|
| Halozyme Therapeutics stock forecast 2024 Jan. | $62.18 | -0.93% |
| Halozyme Therapeutics stock forecast 2024 Feb. | $61.53 | -1.05% |
| Halozyme Therapeutics stock forecast 2024 Mar. | $61.04 | -0.80% |
| Halozyme Therapeutics stock forecast 2024 Apr. | $60.61 | -0.70% |
| Halozyme Therapeutics stock forecast 2024 May. | $60.06 | -0.92% |
| Halozyme Therapeutics stock forecast 2024 Jun. | $59.61 | -0.74% |
| Halozyme Therapeutics stock forecast 2024 Jul. | $59.20 | -0.69% |
| Halozyme Therapeutics stock forecast 2024 Aug. | $59.99 | 1.34% |
| Halozyme Therapeutics stock forecast 2024 Sep. | $60.36 | 0.61% |
| Halozyme Therapeutics stock forecast 2024 Oct. | $60.08 | -0.45% |
| Halozyme Therapeutics stock forecast 2024 Nov. | $59.63 | -0.76% |
| Halozyme Therapeutics stock forecast 2024 Dec. | $58.92 | -1.18% |
Halozyme Therapeutics (HALO) stock forecast 2025
| Date | Price Target | Change |
|---|---|---|
| Halozyme Therapeutics stock forecast 2025 Jan. | $58.14 | -1.33% |
| Halozyme Therapeutics stock forecast 2025 Feb. | $57.35 | -1.36% |
| Halozyme Therapeutics stock forecast 2025 Mar. | $56.59 | -1.33% |
| Halozyme Therapeutics stock forecast 2025 Apr. | $56.14 | -0.78% |
| Halozyme Therapeutics stock forecast 2025 May. | $55.91 | -0.41% |
| Halozyme Therapeutics stock forecast 2025 Jun. | $55.71 | -0.36% |
| Halozyme Therapeutics stock forecast 2025 Jul. | $55.48 | -0.41% |
| Halozyme Therapeutics stock forecast 2025 Aug. | $55.24 | -0.43% |
| Halozyme Therapeutics stock forecast 2025 Sep. | $55.13 | -0.21% |
| Halozyme Therapeutics stock forecast 2025 Oct. | $55.09 | -0.07% |
| Halozyme Therapeutics stock forecast 2025 Nov. | $54.91 | -0.32% |
| Halozyme Therapeutics stock forecast 2025 Dec. | $54.43 | -0.87% |
Halozyme Therapeutics (HALO) stock forecast 2026
| Date | Price Target | Change |
|---|---|---|
| Halozyme Therapeutics stock forecast 2026 Jan. | $53.66 | -1.43% |
| Halozyme Therapeutics stock forecast 2026 Feb. | $52.78 | -1.62% |
| Halozyme Therapeutics stock forecast 2026 Mar. | $52.05 | -1.39% |
| Halozyme Therapeutics stock forecast 2026 Apr. | $51.47 | -1.11% |
| Halozyme Therapeutics stock forecast 2026 May. | $51.01 | -0.90% |
| Halozyme Therapeutics stock forecast 2026 Jun. | $50.67 | -0.68% |
| Halozyme Therapeutics stock forecast 2026 Jul. | $50.42 | -0.48% |
| Halozyme Therapeutics stock forecast 2026 Aug. | $50.26 | -0.32% |
| Halozyme Therapeutics stock forecast 2026 Sep. | $50.16 | -0.20% |
| Halozyme Therapeutics stock forecast 2026 Oct. | $50.11 | -0.10% |
| Halozyme Therapeutics stock forecast 2026 Nov. | $50.10 | -0.01% |
| Halozyme Therapeutics stock forecast 2026 Dec. | $50.15 | 0.10% |
Halozyme Therapeutics (HALO) stock forecast 2027
| Date | Price Target | Change |
|---|---|---|
| Halozyme Therapeutics stock forecast 2027 Jan. | $50.27 | 0.23% |
| Halozyme Therapeutics stock forecast 2027 Feb. | $50.46 | 0.37% |
| Halozyme Therapeutics stock forecast 2027 Mar. | $50.69 | 0.47% |
| Halozyme Therapeutics stock forecast 2027 Apr. | $50.94 | 0.49% |
| Halozyme Therapeutics stock forecast 2027 May. | $51.19 | 0.49% |
| Halozyme Therapeutics stock forecast 2027 Jun. | $51.45 | 0.51% |
| Halozyme Therapeutics stock forecast 2027 Jul. | $51.72 | 0.51% |
| Halozyme Therapeutics stock forecast 2027 Aug. | $51.97 | 0.49% |
| Halozyme Therapeutics stock forecast 2027 Sep. | $52.20 | 0.44% |
| Halozyme Therapeutics stock forecast 2027 Oct. | $52.38 | 0.34% |
| Halozyme Therapeutics stock forecast 2027 Nov. | $52.51 | 0.25% |
| Halozyme Therapeutics stock forecast 2027 Dec. | $52.59 | 0.16% |
Halozyme Therapeutics (HALO) stock forecast 2028
| Date | Price Target | Change |
|---|---|---|
| Halozyme Therapeutics stock forecast 2028 Jan. | $52.63 | 0.08% |
| Halozyme Therapeutics stock forecast 2028 Feb. | $52.64 | 0.02% |
| Halozyme Therapeutics stock forecast 2028 Mar. | $52.63 | -0.03% |
| Halozyme Therapeutics stock forecast 2028 Apr. | $52.60 | -0.05% |
| Halozyme Therapeutics stock forecast 2028 May. | $52.57 | -0.06% |
| Halozyme Therapeutics stock forecast 2028 Jun. | $52.54 | -0.07% |
| Halozyme Therapeutics stock forecast 2028 Jul. | $52.50 | -0.07% |
| Halozyme Therapeutics stock forecast 2028 Aug. | $52.47 | -0.06% |
| Halozyme Therapeutics stock forecast 2028 Sep. | $52.44 | -0.06% |
| Halozyme Therapeutics stock forecast 2028 Oct. | $52.41 | -0.05% |
| Halozyme Therapeutics stock forecast 2028 Nov. | $52.38 | -0.05% |
| Halozyme Therapeutics stock forecast 2028 Dec. | $52.35 | -0.05% |
Halozyme Therapeutics (HALO) stock forecast 2029
| Date | Price Target | Change |
|---|---|---|
| Halozyme Therapeutics stock forecast 2029 Jan. | $52.33 | -0.05% |
| Halozyme Therapeutics stock forecast 2029 Feb. | $52.30 | -0.05% |
| Halozyme Therapeutics stock forecast 2029 Mar. | $52.27 | -0.05% |
| Halozyme Therapeutics stock forecast 2029 Apr. | $52.24 | -0.05% |
| Halozyme Therapeutics stock forecast 2029 May. | $52.22 | -0.05% |
| Halozyme Therapeutics stock forecast 2029 Jun. | $52.19 | -0.05% |
| Halozyme Therapeutics stock forecast 2029 Jul. | $52.17 | -0.04% |
| Halozyme Therapeutics stock forecast 2029 Aug. | $52.15 | -0.03% |
| Halozyme Therapeutics stock forecast 2029 Sep. | $52.14 | -0.02% |
| Halozyme Therapeutics stock forecast 2029 Oct. | $52.14 | -0.00% |
| Halozyme Therapeutics stock forecast 2029 Nov. | $52.15 | 0.01% |
| Halozyme Therapeutics stock forecast 2029 Dec. | $52.16 | 0.02% |
Halozyme Therapeutics (HALO) stock forecast 2030
| Date | Price Target | Change |
|---|---|---|
| Halozyme Therapeutics stock forecast 2030 Jan. | $52.17 | 0.03% |
| Halozyme Therapeutics stock forecast 2030 Feb. | $52.19 | 0.04% |
| Halozyme Therapeutics stock forecast 2030 Mar. | $52.22 | 0.05% |
| Halozyme Therapeutics stock forecast 2030 Apr. | $52.25 | 0.06% |
| Halozyme Therapeutics stock forecast 2030 May. | $52.30 | 0.09% |
| Halozyme Therapeutics stock forecast 2030 Jun. | $52.36 | 0.13% |
| Halozyme Therapeutics stock forecast 2030 Jul. | $52.46 | 0.18% |
| Halozyme Therapeutics stock forecast 2030 Aug. | $52.59 | 0.25% |
| Halozyme Therapeutics stock forecast 2030 Sep. | $52.76 | 0.34% |
| Halozyme Therapeutics stock forecast 2030 Oct. | $52.99 | 0.44% |
| Halozyme Therapeutics stock forecast 2030 Nov. | $53.28 | 0.54% |
| Halozyme Therapeutics stock forecast 2030 Dec. | $53.61 | 0.63% |
Halozyme Therapeutics (HALO) stock forecast 2031
| Date | Price Target | Change |
|---|---|---|
| Halozyme Therapeutics stock forecast 2031 Jan. | $53.99 | 0.69% |
| Halozyme Therapeutics stock forecast 2031 Feb. | $54.38 | 0.74% |
| Halozyme Therapeutics stock forecast 2031 Mar. | $54.80 | 0.77% |
| Halozyme Therapeutics stock forecast 2031 Apr. | $55.23 | 0.79% |
| Halozyme Therapeutics stock forecast 2031 May. | $55.68 | 0.81% |
| Halozyme Therapeutics stock forecast 2031 Jun. | $56.14 | 0.83% |
| Halozyme Therapeutics stock forecast 2031 Jul. | $56.61 | 0.84% |
| Halozyme Therapeutics stock forecast 2031 Aug. | $57.08 | 0.84% |
| Halozyme Therapeutics stock forecast 2031 Sep. | $57.54 | 0.80% |
Financial Data for Halozyme Therapeutics stock
Frequently Asked Questions about Halozyme Therapeutics stock forecast
Is Halozyme Therapeutics a good long term stock?
From Halozyme Therapeutics stock forecast , Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for 2021 Oct. is $39.8519070593579 From Halozyme Therapeutics stock forecast , Halozyme Therapeutics (HALO) stock can be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for 2022 Sep. is $64.4100679681999 From Halozyme Therapeutics stock forecast , Halozyme Therapeutics (HALO) stock can be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for 2025 Sep. is $55.1268598649729 From Halozyme Therapeutics stock forecast , Halozyme Therapeutics (HALO) stock can be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for 2026 Sep. is $50.1584118470937 From Halozyme Therapeutics stock forecast , Halozyme Therapeutics (HALO) stock can be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for 2030 Sep. is $52.7646129834251 From Halozyme Therapeutics stock forecast , Halozyme Therapeutics (HALO) stock can be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for 2031 Sep. is $57.541762144457
Is Halozyme Therapeutics stock overvalued?
Halozyme Therapeutics (HALO) stock is expected to go UP . Therefore, AI Pickup would say that Halozyme Therapeutics (HALO) stock is NOT overvalued.
Will Halozyme Therapeutics stock price go up?
Yes. The Halozyme Therapeutics stock price forecast for 2022 Sep. is $64.4100679681999
Is Halozyme Therapeutics stock a good buy now?
Since closing price on 2021-09-24 is $40.2900009155273 and forecast for 2022 Sep. is $64.41, Halozyme Therapeutics stock is a good 1 year investment.